Bio Solution Co Ltd banner
B

Bio Solution Co Ltd
KOSDAQ:086820

Watchlist Manager
Bio Solution Co Ltd
KOSDAQ:086820
Watchlist
Price: 11 800 KRW 1.64% Market Closed
Market Cap: ₩286.6B

Balance Sheet

Balance Sheet Decomposition
Bio Solution Co Ltd

Balance Sheet
Bio Solution Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
677
1 472
2 774
1 510
3 393
28 956
13 444
5 486
12 922
Cash
677
1 472
2 774
0
0
0
0
0
0
Cash Equivalents
0
0
0
1 510
3 393
28 956
13 444
5 486
12 922
Short-Term Investments
1 906
800
42 079
38 970
32 812
54 127
59 357
32 224
1 428
Total Receivables
2 156
1 294
2 870
3 706
3 057
2 602
4 659
4 780
5 061
Accounts Receivables
2 148
1 291
2 850
3 475
2 786
2 318
4 014
4 177
4 637
Other Receivables
8
3
20
231
271
283
646
602
424
Inventory
550
616
693
530
1 328
1 203
1 466
1 453
1 492
Other Current Assets
54
115
69
78
98
167
233
296
79
Total Current Assets
5 342
4 297
48 486
44 793
40 687
87 055
79 159
44 239
20 983
PP&E Net
2 289
1 942
1 817
4 105
5 230
3 945
8 448
6 914
6 450
PP&E Gross
2 289
1 942
1 817
4 105
5 230
3 945
8 448
6 914
6 450
Accumulated Depreciation
4 716
5 260
3 972
5 474
5 967
7 684
8 191
9 864
8 849
Intangible Assets
736
731
975
1 139
2 112
2 644
3 098
3 349
3 591
Note Receivable
0
0
0
0
0
0
0
325
537
Long-Term Investments
0
0
1 074
1 087
1 092
0
0
36 575
34 752
Other Long-Term Assets
453
409
513
684
677
760
1 026
946
1 151
Total Assets
8 821
N/A
7 378
-16%
52 865
+617%
51 807
-2%
49 798
-4%
94 404
+90%
91 731
-3%
92 347
+1%
67 464
-27%
Liabilities
Accounts Payable
253
257
226
99
195
149
1 242
278
459
Accrued Liabilities
114
126
132
165
166
207
259
332
294
Short-Term Debt
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
611
781
28 580
31 792
34 941
27 268
Other Current Liabilities
1 161
1 143
1 461
1 937
878
19 925
12 559
11 504
5 363
Total Current Liabilities
1 528
1 526
1 819
2 812
2 021
48 861
45 853
47 055
33 384
Long-Term Debt
0
0
0
150
653
47
1 345
731
971
Other Liabilities
1 170
1 435
1 983
749
460
484
757
2 432
1 852
Total Liabilities
2 698
N/A
2 961
+10%
3 802
+28%
3 711
-2%
3 134
-16%
49 391
+1 476%
47 955
-3%
50 218
+5%
36 207
-28%
Equity
Common Stock
3 063
3 063
3 924
4 018
4 046
4 054
4 072
4 072
4 072
Retained Earnings
9 852
11 760
10 528
12 706
14 676
16 536
24 505
26 322
38 116
Additional Paid In Capital
12 911
13 114
55 668
56 784
57 295
57 282
63 929
63 929
62 900
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
1 910
Other Equity
0
0
0
0
0
213
279
450
492
Total Equity
6 122
N/A
4 417
-28%
49 063
+1 011%
48 097
-2%
46 664
-3%
45 013
-4%
43 775
-3%
42 130
-4%
31 257
-26%
Total Liabilities & Equity
8 821
N/A
7 378
-16%
52 865
+617%
51 807
-2%
49 798
-4%
94 404
+90%
91 731
-3%
92 347
+1%
67 464
-27%
Shares Outstanding
Common Shares Outstanding
18
18
23
24
24
24
24
24
24
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett